|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.17 HKD | +2.36% |
|
+4.33% | -14.90% |
| Apr. 22 | Shanghai Fudan-Zhangjiang Buys Structured Deposits Worth 200 Million Yuan | MT |
| Apr. 01 | Fudan-Zhangjiang Bio Sees Profit, Revenue Drop in 2023 | MT |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 707.96 million compared to CNY 716.27 million a year ago. Net income was CNY 89.89 million compared to CNY 36.82 million a year ago.
Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.04 a year ago. Diluted earnings per share from continuing operations was CNY 0.09.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.90% | 818M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. 
